GGrantIndex
← Search

Healthy Cervix: A Clinic Community Health Educator-Based Cervical Cancer Education, Prevention and Screening Program (HEALIX)

$197,070P30FY2023CANIH

University Of California At Davis, Davis CA

Investigators

Linked publications, trials & patents

Paper 39725713Paper 39620216Paper 39616300Paper 39488208Paper 39453739Paper 39440945Paper 39384967Paper 39383000Paper 39350111Paper 39345479Paper 39345391Paper 39257973Paper 39252929Paper 39217266Paper 39177582Paper 39168154Paper 39108503Paper 39103353Paper 39056190Paper 39046599Paper 39012466Paper 38990223Paper 38979288Paper 38969563Paper 38947002Paper 38885336Paper 38877132Paper 38865710Paper 38843382Paper 38826195Paper 38803393Paper 38798575Paper 38780011Trial NCT07304011Trial NCT07258446Trial NCT07209215Trial NCT07189195Trial NCT07145112Trial NCT06905509Trial NCT06854159Trial NCT06211335Trial NCT06178354Trial NCT06173362Trial NCT06173349Trial NCT06103682Trial NCT06103669Trial NCT06067776Trial NCT05967533Trial NCT05843448Trial NCT05600686Trial NCT05479578Trial NCT05110781Trial NCT05101356Trial NCT05052528Trial NCT04964505Trial NCT04905810Trial NCT04856189Trial NCT04716699Trial NCT04587687Trial NCT04578600Trial NCT04552704Trial NCT04450173Trial NCT04410302Trial NCT04186988Trial NCT04050085Trial NCT04030559Trial NCT03695250Trial NCT03359460Trial NCT03299088Trial NCT03164486Trial NCT03123978Trial NCT02997761Trial NCT02935205Trial NCT02823990Trial NCT02807805Trial NCT02569723Trial NCT02400814Trial NCT02364609Trial NCT02348255Trial NCT02339168Trial NCT02178241Trial NCT02077998Trial NCT01924260Trial NCT01923337Trial NCT01911507Trial NCT01008566Trial NCT00918645Trial NCT00810719Trial NCT00804310Trial NCT00795665Trial NCT00628654Trial NCT00467077Trial NCT00408499Trial NCT00390429Trial NCT00389922Trial NCT00388115Trial NCT00388089Trial NCT00387660Trial NCT00387322Trial NCT00376727

Abstract

PROJECT SUMMARY Widespread use of the human papilloma virus (HPV) vaccine coupled with early detection is expected to reduce the cervical cancer burden across all racial/ethnic groups and mitigate disparities as women of color are disproportionately affected by cervical cancer. To address the current dearth of effective preventative programs embedded within the community health clinic system, where most of the underserved populations receive care, we developed the Healthy Cervix program, a community clinic health educator-based cervical cancer education, prevention and screening effort, (“HEALIX”) built as a community engaged research collaboration between the University of California, Davis Comprehensive Cancer Center and Peach Tree Health (Peach Tree), a Federally Qualified Health Center (FQHC). HEALIX is grounded in a multilevel health equity framework merging a community health worker-led outreach and education model approach with cervical cancer training for primary care teams, and the option of both HPVself-collectionand clinical Papanicolaou (Pap) testing for clients/patients. The primary goal of this study is to evaluate the acceptability, appropriateness, and feasibility of implementing this multilevel intervention, which addresses individual, community, and systems level barriers, on increasing HPV completion rates among patients ages 9-17 and Pap testing among women ages 21-65 in three of Peach Tree’s clinics compared to usual care. This will be accomplished through the following aims: Aim 1) Customize and contextualize cervical cancer prevention communications, education strategies and multi-media delivery modes that will inform necessary adaptations to the proposed multilevel intervention; and Aim 2) Pilot the HEALIX multilevel intervention in three Peach Tree clinics, evaluating selected implementation outcomes and exploring service (screening/vaccination rates) and client/patient (satisfaction) outcomes. The proposed research is significant because it will contribute to the field of multilevel intervention research to mitigate cervical cancer disparities and addresses the need for more scientifically rigorous, evidence-based interventions that can be disseminated and implemented in diverse communities. Successful achievement of our Aims will significantly increase HPV vaccination and Pap testing rates over baseline, advance our understanding of the utility of HPV self-collection kits in community settings; and will provide insights on strategies that can be utilized to address other cancer health disparities impacting women. Furthermore, given the paucity of effective multilevel interventions to increase HPV vaccine uptake and Pap testing in understudied, underrepresented, and underreported communities, this study can guide effective dissemination and implementation of empirically derived evidence-based interventions for health care delivery systems serving rural, racially/ethnically diverse, and socially disadvantaged communities.

View original record on NIH RePORTER →